主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
QURE
#2145
uniQure N.V.
15.6
3
-9.76%
版块:
基础:
利润货币:
日范围
年范围
日变化
-9.76%
每月变动
-34.90%
6个月变化
-1.01%
年变化
+33.02%
前一天收盘价
17.3
2
Open
15.6
3
Bid
Ask
Low
15.6
3
High
15.6
3
交易量
137
市场
股票
医疗保健
QURE
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
uniQure N.V
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
新闻
uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know (NASDAQ:QURE)
uniQure财报受关注,AMT-130监管前景成焦点
uniQure earnings in focus as AMT-130 regulatory path looms
Stifel就FDA局长言论评论uniQure股票
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Applied Materials, Broadcom among market cap stock movers on Thursday
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
FDA对基因疗法试验发表评论后UniQure股价暴跌
UniQure stock tumbles on FDA comments about gene therapy trial
Wolfe Research首次覆盖uniQure股票,评级为同业表现
uniQure stock initiated at Peerperform by Wolfe Research